Trial Profile
A tolerability, safety study of single dose progressively increasing, random, double-blinded placebo-controlled in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Sep 2014
Price :
$35
*
At a glance
- Drugs Ulinastatin (Primary)
- Indications Pancreatitis; Severe acute respiratory syndrome; Vascular disorders
- Focus Adverse reactions
- Sponsors Guangdong Techpool Bio-Pharma
- 23 Sep 2014 New trial record